BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22715214)

  • 1. Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.
    Smith BD; Jorgensen C; Zibbell JE; Beckett GA
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S49-53. PubMed ID: 22715214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus prevention, care, and treatment: from policy to practice.
    Ward JW; Valdiserri RO; Koh HK
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S58-63. PubMed ID: 22715216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of hepatitis C: considerations for healthcare providers in the United States.
    Averhoff FM; Glass N; Holtzman D
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S10-5. PubMed ID: 22715208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities to address the hepatitis C epidemic in the correctional setting.
    Boutwell AE; Allen SA; Rich JD
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(29):545-9. PubMed ID: 22832935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of hepatitis C virus-related public inquiries from health professionals: 2009-2010.
    Jorgensen CM; Lewis CA; Liu J
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S54-7. PubMed ID: 22715215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning a hepatitis C postexposure management program for health care workers. Issues and challenges.
    Haiduven DJ
    AAOHN J; 2000 Aug; 48(8):370-5. PubMed ID: 11760299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of preventing hepatitis C virus infection among injection drug users in the United States.
    Alter MJ; Moyer LA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S6-10. PubMed ID: 9663617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
    Smith BD; Morgan RL; Beckett GA; Falck-Ytter Y; Holtzman D; Teo CG; Jewett A; Baack B; Rein DB; Patel N; Alter M; Yartel A; Ward JW;
    MMWR Recomm Rep; 2012 Aug; 61(RR-4):1-32. PubMed ID: 22895429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National surveillance of dialysis associated diseases in the United States, 1993.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus infection among clients of HIV counseling and testing sites--Connecticut, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(27):577-81. PubMed ID: 11475165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages.
    Kanwal F; Lok AS; El-Serag HB
    Gastroenterology; 2013 Mar; 144(3):478-81. PubMed ID: 23419454
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.